User profiles for Lisa E. Hensley
 | Lisa E HensleyResearch Lead Zoonotic and emerging disease research unit Verified email at usda.gov Cited by 28845 |
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
…, VE Volchkov, EA Fritz, KM Daddario, LE Hensley… - Nature medicine, 2005 - nature.com
Vaccines and therapies are urgently needed to address public health needs stemming from
emerging pathogens and biological threat agents such as the filoviruses Ebola virus (EBOV) …
emerging pathogens and biological threat agents such as the filoviruses Ebola virus (EBOV) …
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection
…, CM Lear-Rooney, PJ Glass, LE Hensley… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Outbreaks of emerging infections present health professionals with the unique challenge of
trying to select appropriate pharmacologic treatments in the clinic with little time available for …
trying to select appropriate pharmacologic treatments in the clinic with little time available for …
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection
TW Geisbert, LE Hensley, T Larsen, HA Young… - The American journal of …, 2003 - Elsevier
Ebola virus (EBOV) infection causes a severe and fatal hemorrhagic disease that in many
ways appears to be similar in humans and nonhuman primates; however, little is known about …
ways appears to be similar in humans and nonhuman primates; however, little is known about …
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo
…, E Okitolonda, LE Hensley… - Proceedings of the …, 2010 - National Acad Sciences
Studies on the burden of human monkeypox in the Democratic Republic of the Congo (DRC)
were last conducted from 1981 to 1986. Since then, the population that is immunologically …
were last conducted from 1981 to 1986. Since then, the population that is immunologically …
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
…, S de Jong, I Tavakoli, A Judge, LE Hensley… - The Lancet, 2010 - thelancet.com
Background We previously showed that small interfering RNAs (siRNAs) targeting the Zaire
Ebola virus (ZEBOV) RNA polymerase L protein formulated in stable nucleic acid-lipid …
Ebola virus (ZEBOV) RNA polymerase L protein formulated in stable nucleic acid-lipid …
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2
…, R Gross, L Wronka, K Caviness, LE Hensley… - Nature …, 2020 - nature.com
The COVID-19 pandemic has highlighted that new diagnostic technologies are essential for
controlling disease transmission. Here, we develop SHINE (Streamlined Highlighting of …
controlling disease transmission. Here, we develop SHINE (Streamlined Highlighting of …
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
TW Geisbert, LE Hensley, PB Jahrling, T Larsen… - The Lancet, 2003 - thelancet.com
Background Infection with the Ebola virus induces overexpression of the procoagulant
tissue factor in primate monocytes and macrophages, suggesting that inhibition of the tissue-…
tissue factor in primate monocytes and macrophages, suggesting that inhibition of the tissue-…
Molecular evidence of sexual transmission of Ebola virus
<p id="p001">A suspected case of sexual transmission from a male survivor of Ebola virus
disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March …
disease (EVD) to his female partner (the patient in this report) occurred in Liberia in March …
Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia
…, SC Sameroff, E de Wit, VJ Munster, LE Hensley… - MBio, 2014 - Am Soc Microbiol
The Middle East respiratory syndrome (MERS) is proposed to be a zoonotic disease;
however, the reservoir and mechanism for transmission of the causative agent, the MERS …
however, the reservoir and mechanism for transmission of the causative agent, the MERS …
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event
…, KJ Davis, E Kagan, LE Hensley - The Journal of …, 2003 - academic.oup.com
Disseminated intravascular coagulation is a prominent manifestation of Ebola virus (EBOV)
infection. Here, we report that tissue factor (TF) plays an important role in triggering the …
infection. Here, we report that tissue factor (TF) plays an important role in triggering the …
